Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 8/20 | 0.48 |
| ▸ | GGPS1 | O95749 | 5/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 4/20 | 0.46 |
| ▸ | PPARD | Q03181 | 4/20 | 0.46 |
| ▸ | PPARA | Q07869 | 4/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.46 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.46 |
| ▸ | TLR2 | O60603 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | FABP4 | P15090 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | PDE4A | P27815 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2506269 | 1.00 | FDPS (0.48) | FDPSGGPS1CES2PPARGPPARD | |
| SCHEMBL7081692 | 1.00 | FDPS (0.48) | FDPSGGPS1CES2PPARGPPARD | |
| SCHEMBL8856371 | 1.00 | FDPS (0.48) | FDPSGGPS1CES2PPARGPPARD | |
| SCHEMBL438946 | 1.00 | FDPS (0.48) | FDPSGGPS1CES2PPARGPPARD | |
| SCHEMBL9097992 | 1.00 | FDPS (0.48) | FDPSGGPS1CES2PPARGPPARD | |
| SCHEMBL11220213 | 1.00 | FDPS (0.48) | FDPSGGPS1CES2PPARGPPARD | |
| SCHEMBL3916862 | 1.00 | FDPS (0.48) | FDPSGGPS1CES2PPARGPPARD | |
| SCHEMBL6556927 | 1.00 | FDPS (0.48) | FDPSGGPS1CES2PPARGPPARD | |
| SCHEMBL35099 | 1.00 | FDPS (0.48) | FDPSGGPS1CES2PPARGPPARD | |
| SCHEMBL15278 | 1.00 | FDPS (0.48) | FDPSGGPS1CES2PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11112717-B2 | Electrostatic ink compositions and scratch-off structures | HP INDIGO B.V. (NL) | 2021-09-07 | — | — | US | claimed |
| EP-1743660-B1 | Antimicrobial sutures and methods of making them | TYCO HEALTHCARE (US) | 2010-06-02 | — | — | EP | claimed |
| US-20070122508-A1 | Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease | HELIXIR CO., LTD. (KR) | 2007-05-31 | — | — | US | claimed |
| US-20050187337-A1 | Thermoplastic vulcanizate with improved surface properties | POLYONE CORPORATION | 2005-08-25 | — | — | US | claimed |
| EP-0793481-B1 | COSMETIC COMPOSITION CONTAINING HYDROXY ALKANOATE DERIVATIVES | UNILEVER PLC (GB) | 2004-06-02 | — | — | EP | claimed |
| EP-0802254-B1 | Refrigerator oil composition | IDEMITSU KOSAN CO (JP) | 2003-07-09 | — | — | EP | claimed |
| EP-0824577-B1 | LUBRICANT FOR VARNISHED WIRES | SCHENECTADY INT INC (US) | 2001-08-01 | — | — | EP | claimed |
| EP-0705094-B1 | SKIN AND SCALP BARRIER FOR USE WITH HAIR TREATMENT PRODUCTS | CARSON PROD CO (US) | 2000-05-24 | — | — | EP | claimed |
| US-6008169-A | Refrigerator oil composition comprising saturated hydroxy fatty acids and derivatives thereof | IDEMITSU KOSAN CO., LTD. (JP) | 1999-12-28 | — | — | US | claimed |
| EP-0713385-B1 | CLEANSING COMPOSITIONS CONTAINING AN ALKANOATE AS CONDITIONER | UNILEVER PLC (GB) | 1999-03-24 | — | — | EP | claimed |
| US-5795695-A | PHOTO-QUALITY RECORDING | XEROX CORPORATION (US) | 1998-08-18 | — | — | US | claimed |
| EP-0151859-B1 | GREASE COMPOSITION | MOBIL OIL CORPORATION (US) | 1992-06-24 | — | — | EP | claimed |
| US-4173492-A | Method of preparing coated pigment particles and the product produced thereby | POLLARD EDWARD T | 1979-11-06 | — | — | US | claimed |
| US-12616730-B2 | Topical composition comprising an extract of combined herbs comprising longanae arillus for the treatment or alleviation of skin ulcer and the use thereof | MEDIHELPLINE CO., LTD (KR) | 2026-05-05 | — | — | US | disclosed |
| EP-4554548-A1 | COSMETIC COMPOSITION COMPRISING SELECTED OIL AND DIOL | L'OREAL (FR) | 2025-05-21 | — | — | EP | disclosed |
| CN-119677492-A | Composition comprising a skin care active or a cellulose compound | 莱雅公司 | 2025-03-21 | — | — | CN | disclosed |
| EP-0133353-B1 | PROCESS FOR PRODUCING PRESSURE-FIXABLE TONERS | FUJIKURA KASEI CO., LTD. (JP) | 1988-10-05 | — | — | EP | disclosed |
| US-4702989-A | DISPERSING COLORANT OR MAGNETIC PARTICLES, BINDER, ENCAPSULATING RESIN; HEATING AND EXTRACTING SOLVENT; DRYING | FUJIKURA KASEI CO., LTD. (JP) | 1987-10-27 | — | — | US | disclosed |
| US-4564534-A | Heat-sensitive transfer material and heat-sensitive transfer recording method | CANON KABUSHIKI KAISHA (JP) | 1986-01-14 | — | — | US | disclosed |
| EP-0133353-A2 | Process for producing pressure-fixable toners | FUJIKURA KASEI CO., LTD. (JP) | 1985-02-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12616730-B2 | Topical composition comprising an extract of combined herbs comprising longanae arillus for the treatment or alleviation of skin ulcer and the use thereof | CUTA, VEGFA, MMP8 | FDPS 4513/4885GGPS1 4132/4885CES2 4399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.